ArticleHuman gene therapy2022

Modulating Oncolytic Adenovirus Immunotherapy by Driving Two Axes of the Immune System by Expressing 4-1BBL and CD40L.

Shao-Chia Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.